Clarus Therapeutics Holdings, Inc.

暂不支持查看OTC详情

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
暂无内容
公司概况
公司名称
Clarus Therapeutics Holdings, Inc.
所属市场
PINK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.clarustherapeutics.com;www.jatenzo.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Clarus Therapeutics Holdings, Inc.是一家于2020年5月22日在特拉华州注册成立的公司。该公司是一家制药公司，在开发男性和女性雄激素和代谢疗法方面具有专业知识，包括针对孤儿适应症的潜在疗法。公司的第一个商业产品是JATENZO。
- 2023-03-01
  员工持股计划
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2023-03-01
  重要事件披露
  8-K - Current report
  8-K - Current report
- 2023-02-22
  重要事件披露
  8-K - Current report
  8-K - Current report
- 2023-02-14
  超过5%披露
  SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
  SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
- 2023-01-24
  重要事件披露
  8-K - Current report
  8-K - Current report
- 2022-12-22
  重要事件披露
  8-K - Current report
  8-K - Current report
- 2022-11-23
  重要事件披露
  8-K - Current report
  8-K - Current report
- 2022-10-31
  重要事件披露
  8-K - Current report
  8-K - Current report
- 2022-10-24
  重要事件披露
  8-K - Current report
  8-K - Current report
- 2022-10-18
  重要事件披露
  8-K - Current report
  8-K - Current report
- 2022-09-15
  重要事件披露
  8-K - Current report
  8-K - Current report
- 2022-09-14
  交易所摘牌声明
  25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
- 2022-09-06
  重要事件披露
  8-K - Current report
  8-K - Current report
- 2022-08-26
  重要事件披露
  8-K - Current report
  8-K - Current report
- 2022-08-19
  季度报告
  10-Q - Quarterly report [Sections 13 or 15(d)]
  10-Q - Quarterly report [Sections 13 or 15(d)]

暂不提供行情数据

热议股票

{"pagemeta":{"title":"Clarus Therapeutics Holdings, Inc.(CRXT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Clarus Therapeutics Holdings, Inc.(CRXT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Clarus Therapeutics Holdings, Inc.,CRXT,Clarus Therapeutics Holdings, Inc.股票,Clarus Therapeutics Holdings, Inc.股票老虎,Clarus Therapeutics Holdings, Inc.股票老虎国际,Clarus Therapeutics Holdings, Inc.行情,Clarus Therapeutics Holdings, Inc.股票行情,Clarus Therapeutics Holdings, Inc.股价,Clarus Therapeutics Holdings, Inc.股市,Clarus Therapeutics Holdings, Inc.股票价格,Clarus Therapeutics Holdings, Inc.股票交易,Clarus Therapeutics Holdings, Inc.股票购买,Clarus Therapeutics Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Clarus Therapeutics Holdings, Inc.(CRXT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Clarus Therapeutics Holdings, Inc.(CRXT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"CRXT","data":{"stockData":{"symbol":"CRXT","market":"US","secType":"STK","nameCN":"Clarus Therapeutics Holdings, Inc.","latestPrice":0.0475,"timestamp":1768922340000,"preClose":0.0475,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":37519692,"shares":52020700,"eps":-1.066595,"marketStatus":"交易中","change":0,"latestTime":"01-20 10:19:00 EST 延时","open":0.0475,"high":0.0475,"low":0.0475,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-1.066595,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1768942800000},"marketStatusCode":2,"adr":0,"exchange":"PINK","adjPreClose":0.0475,"volumeRatio":0},"tweetData":{"bottom":true,"list":[],"size":0},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"16017792","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390023015844-CRXT","pdf_url":"","pub_time":1677600000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","symbol":"CRXT","title":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","titleType":"员工持股计划","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023015844/0001213900-23-015844-index.htm","us_notice_code":"Form S-8 POS","us_title_en":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023015844/ea174455-s8pos_clarustherap.htm","primary":true,"translateUrl":"","linkName":"ea174455-s8pos_clarustherap.htm","type":"S-8 POS","id":"NTFILE6Us9qB3WweiP9fDF","market":"us","size":26934}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"员工持股计划","pubTime":"2023-03-01 00:00","pubTimestamp":1677600000,"title_zh":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"16017791","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390023015846-CRXT","pdf_url":"","pub_time":1677600000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"CRXT","title":"8-K  - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023015846/0001213900-23-015846-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.03: Bankruptcy or Receivership;\nItem 2.01: Completion of Acquisition or Disposition of Assets;\nItem 3.03: Material Modifications to Rights of Security Holders;\nItem 5.01: Changes in Control of Registrant;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 8.01: Other Events","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023015846/ea174454-8k_clarus.htm","primary":true,"translateUrl":"","linkName":"ea174454-8k_clarus.htm","type":"8-K","id":"NTFILEE13aAgiMaJjUkf4t","market":"us","size":39702}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2023-03-01 00:00","pubTimestamp":1677600000,"title_zh":"8-K  - Current report","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15986552","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390023013683-CRXT","pdf_url":"","pub_time":1676995200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"CRXT","title":"8-K  - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/0001213900-23-013683-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CLARUS THERAPEUTICS HOLDINGS, INC., MONTHLY OPERATING REPORT, DATED FEBRUARY 21,","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ea174113ex99-1_clarustherap.htm","primary":true,"translateUrl":"","linkName":"ea174113ex99-1_clarustherap.htm","type":"EX-99.1","id":"NTFILEB5cmqh3U4SJUcBni","market":"us","size":8966},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ea174113-8k_clarustherap.htm","primary":false,"translateUrl":"","linkName":"ea174113-8k_clarustherap.htm","type":"8-K","id":"NTFILEB2Xft2BBXeqJ1KR6","market":"us","size":46246},{"description":"CLARUS THERAPEUTICS, INC., MONTHLY OPERATING REPORT, DATED FEBRUARY 21, 2023","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ea174113ex99-2_clarustherap.htm","primary":false,"translateUrl":"","linkName":"ea174113ex99-2_clarustherap.htm","type":"EX-99.2","id":"NTFILE2fcYYUEhfGzhg5cE","market":"us","size":8957},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEAJhzjpWs47Rh7Qpu","market":"us","size":148138},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_002.jpg","type":"GRAPHIC","id":"NTFILE3aN2eS7gcoHzGeh5","market":"us","size":184139},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-1_003.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_003.jpg","type":"GRAPHIC","id":"NTFILE2mjztBRsRtn4jB8r","market":"us","size":145154},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-1_004.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_004.jpg","type":"GRAPHIC","id":"NTFILE5aXM21tcb3nsAuws","market":"us","size":135967},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-1_005.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_005.jpg","type":"GRAPHIC","id":"NTFILEFS7ZEWsfCesKJViT","market":"us","size":146606},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-1_006.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_006.jpg","type":"GRAPHIC","id":"NTFILEBcBPQUWofjXR7byK","market":"us","size":136353},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-1_007.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_007.jpg","type":"GRAPHIC","id":"NTFILE4Z2DYRith82ezh3Y","market":"us","size":137270},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-1_008.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_008.jpg","type":"GRAPHIC","id":"NTFILEAD1ebMprXfr8oQMo","market":"us","size":168496},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-1_009.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_009.jpg","type":"GRAPHIC","id":"NTFILEHFpW2yyvZ11PWCoC","market":"us","size":223813},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-1_010.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_010.jpg","type":"GRAPHIC","id":"NTFILE55WGTrWF6hFeDAsa","market":"us","size":384140},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-1_011.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_011.jpg","type":"GRAPHIC","id":"NTFILE8V4b7BRVhfegv2Kv","market":"us","size":368414},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-1_012.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_012.jpg","type":"GRAPHIC","id":"NTFILEJ238BEukp75y8xrf","market":"us","size":224143},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-2_001.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_001.jpg","type":"GRAPHIC","id":"NTFILEEBvEEfPpAacGF2Ar","market":"us","size":147135},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-2_002.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_002.jpg","type":"GRAPHIC","id":"NTFILE68xr8zt8tmtTYV7m","market":"us","size":193796},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-2_003.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_003.jpg","type":"GRAPHIC","id":"NTFILE2MkFE4pbsLpnX7cU","market":"us","size":166931},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-2_004.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_004.jpg","type":"GRAPHIC","id":"NTFILEFadKSwMZSX54rqvi","market":"us","size":135313},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-2_005.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_005.jpg","type":"GRAPHIC","id":"NTFILE8qVoq5MnBKYfA2wH","market":"us","size":152989},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-2_006.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_006.jpg","type":"GRAPHIC","id":"NTFILEDP1bV9Tac3XNPTnj","market":"us","size":135877},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-2_007.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_007.jpg","type":"GRAPHIC","id":"NTFILE6ucmiGR5A25eCj4r","market":"us","size":136769},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-2_008.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_008.jpg","type":"GRAPHIC","id":"NTFILE9oasgVNUaZEvYMY1","market":"us","size":169769},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-2_009.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_009.jpg","type":"GRAPHIC","id":"NTFILEDfvjvNyENnx84CBp","market":"us","size":223112},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-2_010.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_010.jpg","type":"GRAPHIC","id":"NTFILE9Emyqn4YpZa3NVbL","market":"us","size":395136},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-2_011.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_011.jpg","type":"GRAPHIC","id":"NTFILE5gRddy12tuhTYtn6","market":"us","size":399513},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023013683/ex99-2_012.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_012.jpg","type":"GRAPHIC","id":"NTFILE6ZHjYWL4wB5Dz7te","market":"us","size":223173}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2023-02-22 00:00","pubTimestamp":1676995200,"title_zh":"8-K  - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01项：条例FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15954332","market":"us","labels":[],"media":"sec.gov","original_id":"AN117266123001071-CRXT","pdf_url":"","pub_time":1676304000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G/A [Amend]  - Statement of acquisition of beneficial ownership by individuals","symbol":"CRXT","title":"SC 13G/A [Amend]  - Statement of acquisition of beneficial ownership by individuals","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1817944/000117266123001071/0001172661-23-001071-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"SC 13G/A [Amend]  - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1601086/000117266123001071/armistice-crxt123122a1.htm","primary":true,"translateUrl":"","linkName":"armistice-crxt123122a1.htm","type":"SC 13G/A","id":"NTFILEFJt9zzErPw2DevYm","market":"us","size":89166}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2023-02-14 00:00","pubTimestamp":1676304000,"title_zh":"SC 13G/A [Amend]  - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15880678","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390023004819-CRXT","pdf_url":"","pub_time":1674489600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"CRXT","title":"8-K  - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/0001213900-23-004819-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CLARUS THERAPEUTICS HOLDINGS, INC., MONTHLY OPERATING REPORT, DATED JANUARY 23,","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ea172118ex99-1_clarustherap.htm","primary":true,"translateUrl":"","linkName":"ea172118ex99-1_clarustherap.htm","type":"EX-99.1","id":"NTFILE3DjtE4Jm2fLBtUqA","market":"us","size":10305},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ea172118-8k_clarustherap.htm","primary":false,"translateUrl":"","linkName":"ea172118-8k_clarustherap.htm","type":"8-K","id":"NTFILE64DkFJDKa4tGQwMN","market":"us","size":35140},{"description":"CLARUS THERAPEUTICS, INC., MONTHLY OPERATING REPORT, DATED JANUARY 23, 2023","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ea172118ex99-2_clarustherap.htm","primary":false,"translateUrl":"","linkName":"ea172118ex99-2_clarustherap.htm","type":"EX-99.2","id":"NTFILEBAJsqTeYJJZSwVEN","market":"us","size":8851},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEHkRPgc3Phk1Rdnyb","market":"us","size":146218},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_002.jpg","type":"GRAPHIC","id":"NTFILED9sL4ggSug5FScBC","market":"us","size":182503},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-1_003.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_003.jpg","type":"GRAPHIC","id":"NTFILEwLA1RYEsf32gehnA","market":"us","size":144811},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-1_004.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_004.jpg","type":"GRAPHIC","id":"NTFILE5ESxyzLjkApzRAMv","market":"us","size":135139},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-1_005.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_005.jpg","type":"GRAPHIC","id":"NTFILEAc28x6St9zNpq9N7","market":"us","size":145858},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-1_006.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_006.jpg","type":"GRAPHIC","id":"NTFILEHwHvKyv5sP7TLwYQ","market":"us","size":135340},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-1_007.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_007.jpg","type":"GRAPHIC","id":"NTFILEEEQ1mxS8aLVqPmcH","market":"us","size":136438},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-1_008.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_008.jpg","type":"GRAPHIC","id":"NTFILE66dnJkf7XKm3q29D","market":"us","size":166398},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-1_009.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_009.jpg","type":"GRAPHIC","id":"NTFILE3e49CyXa7RR4u5to","market":"us","size":221186},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-1_010.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_010.jpg","type":"GRAPHIC","id":"NTFILE5NQMHRujjxvf4wxw","market":"us","size":390262},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-1_011.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_011.jpg","type":"GRAPHIC","id":"NTFILE7HNnx6nffsBSzMjk","market":"us","size":368333},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-1_012.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_012.jpg","type":"GRAPHIC","id":"NTFILE4s2GKbHArcZfKejH","market":"us","size":223346},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-2_001.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_001.jpg","type":"GRAPHIC","id":"NTFILEB2KSq2My3RcKCGbV","market":"us","size":144975},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-2_002.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_002.jpg","type":"GRAPHIC","id":"NTFILEE8dMtT96VToaaWVC","market":"us","size":191405},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-2_003.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_003.jpg","type":"GRAPHIC","id":"NTFILE4EYDnm5NxScYBqG3","market":"us","size":170245},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-2_004.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_004.jpg","type":"GRAPHIC","id":"NTFILE9nTzeAKLCNw5uffB","market":"us","size":134491},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-2_005.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_005.jpg","type":"GRAPHIC","id":"NTFILECKb5z31VxY6zNdiS","market":"us","size":152069},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-2_006.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_006.jpg","type":"GRAPHIC","id":"NTFILE9NWZBFmUQin8pa9t","market":"us","size":134762},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-2_007.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_007.jpg","type":"GRAPHIC","id":"NTFILE3osztY85iQZ9DcN6","market":"us","size":135791},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-2_008.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_008.jpg","type":"GRAPHIC","id":"NTFILE7qvtKCnATCoAQ8q8","market":"us","size":168519},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-2_009.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_009.jpg","type":"GRAPHIC","id":"NTFILE6ZXYbVWys3fEvn3D","market":"us","size":220682},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-2_010.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_010.jpg","type":"GRAPHIC","id":"NTFILE4NbipyKMMwAB5ru6","market":"us","size":401150},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-2_011.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_011.jpg","type":"GRAPHIC","id":"NTFILEB1fEEkqJ3h8kN5Nv","market":"us","size":398031},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390023004819/ex99-2_012.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_012.jpg","type":"GRAPHIC","id":"NTFILEHf5zVEdXVjs5krGv","market":"us","size":222212}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2023-01-24 00:00","pubTimestamp":1674489600,"title_zh":"8-K  - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01项：条例FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15783375","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390022082213-CRXT","pdf_url":"","pub_time":1671638400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"CRXT","title":"8-K  - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/0001213900-22-082213-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CLARUS THERAPEUTICS HOLDINGS, INC., MONTHLY OPERATING REPORT, DATED DECEMBER 21,","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ea170781ex99-1_clarustherap.htm","primary":true,"translateUrl":"","linkName":"ea170781ex99-1_clarustherap.htm","type":"EX-99.1","id":"NTFILEA9Dxkk2q3LAcLeFx","market":"us","size":7657},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ea170781-8k_clarustherap.htm","primary":false,"translateUrl":"","linkName":"ea170781-8k_clarustherap.htm","type":"8-K","id":"NTFILEJ69pBXYSa4VqikVa","market":"us","size":35550},{"description":"CLARUS THERAPEUTICS, INC., MONTHLY OPERATING REPORT, DATED DECEMBER 21, 2022","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ea170781ex99-2_clarustherap.htm","primary":false,"translateUrl":"","linkName":"ea170781ex99-2_clarustherap.htm","type":"EX-99.2","id":"NTFILEG9XzgtKYiBnX5cwP","market":"us","size":7573},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEFhoGzwUZump34TgF","market":"us","size":146090},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_002.jpg","type":"GRAPHIC","id":"NTFILEF7D2QyKr9rTbEocW","market":"us","size":182670},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-1_003.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_003.jpg","type":"GRAPHIC","id":"NTFILEBT7uEreXtfjJM2Qb","market":"us","size":144811},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-1_004.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_004.jpg","type":"GRAPHIC","id":"NTFILEJ3uwHegbVH13S2kn","market":"us","size":135139},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-1_005.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_005.jpg","type":"GRAPHIC","id":"NTFILEG7Wpm5fWLrHB3xTS","market":"us","size":145858},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-1_006.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_006.jpg","type":"GRAPHIC","id":"NTFILEXAKimix5ZbQVX9Zv","market":"us","size":135340},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-1_007.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_007.jpg","type":"GRAPHIC","id":"NTFILE5Tm2jibXVpDbJkGe","market":"us","size":136438},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-1_008.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_008.jpg","type":"GRAPHIC","id":"NTFILEH7M585cYRRufQKBB","market":"us","size":166398},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-1_009.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_009.jpg","type":"GRAPHIC","id":"NTFILE3nwcUU9513xhPAEH","market":"us","size":221148},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-1_010.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_010.jpg","type":"GRAPHIC","id":"NTFILE3ieKVWbtpLUvvReR","market":"us","size":390234},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-1_011.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_011.jpg","type":"GRAPHIC","id":"NTFILE6xqGChj87A2z7h6o","market":"us","size":368333},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-1_012.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_012.jpg","type":"GRAPHIC","id":"NTFILE6VZU5w2EueNpnt2J","market":"us","size":223411},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-2_001.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_001.jpg","type":"GRAPHIC","id":"NTFILEC7AdJ148n3xffdaQ","market":"us","size":144965},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-2_002.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_002.jpg","type":"GRAPHIC","id":"NTFILE3SWTDPuDbgwBC9XQ","market":"us","size":197657},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-2_003.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_003.jpg","type":"GRAPHIC","id":"NTFILE12fszNvNCD2CnYm6","market":"us","size":167732},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-2_004.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_004.jpg","type":"GRAPHIC","id":"NTFILE7j4LsniezovTL7j5","market":"us","size":134491},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-2_005.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_005.jpg","type":"GRAPHIC","id":"NTFILEESoZtsDLUpDN9uCh","market":"us","size":152069},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-2_006.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_006.jpg","type":"GRAPHIC","id":"NTFILEP8wV2y6VeSE67XQP","market":"us","size":134762},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-2_007.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_007.jpg","type":"GRAPHIC","id":"NTFILEEtxDKEjfMZyN8zRR","market":"us","size":135791},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-2_008.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_008.jpg","type":"GRAPHIC","id":"NTFILE5bZtzHFbFisxdFQf","market":"us","size":167421},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-2_009.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_009.jpg","type":"GRAPHIC","id":"NTFILEBEnvprpsUyhrrzEK","market":"us","size":220615},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-2_010.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_010.jpg","type":"GRAPHIC","id":"NTFILE4Euio1G6kevcN96G","market":"us","size":397910},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-2_011.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_011.jpg","type":"GRAPHIC","id":"NTFILEAL8UPwShT2piPq6R","market":"us","size":396604},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022082213/ex99-2_012.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_012.jpg","type":"GRAPHIC","id":"NTFILE6azTQedTP9Yumn3d","market":"us","size":222628}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2022-12-22 00:00","pubTimestamp":1671638400,"title_zh":"8-K  - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01项：条例FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15689522","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390022074705-CRXT","pdf_url":"","pub_time":1669132800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"CRXT","title":"8-K  - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/0001213900-22-074705-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CLARUS THERAPEUTICS HOLDINGS, INC., MONTHLY OPERATING REPORT, DATED NOVEMBER 21,","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ea169173ex99-1_clarus.htm","primary":true,"translateUrl":"","linkName":"ea169173ex99-1_clarus.htm","type":"EX-99.1","id":"NTFILEdboJcjhcCX4rpmrW","market":"us","size":8927},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ea169173-8k_clarus.htm","primary":false,"translateUrl":"","linkName":"ea169173-8k_clarus.htm","type":"8-K","id":"NTFILE96AZbpRqGWvfz1EJ","market":"us","size":34068},{"description":"CLARUS THERAPEUTICS, INC., MONTHLY OPERATING REPORT, DATED NOVEMBER 21, 2022","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ea169173ex99-2_clarus.htm","primary":false,"translateUrl":"","linkName":"ea169173ex99-2_clarus.htm","type":"EX-99.2","id":"NTFILEkLHmJLXHaRnkXcvC","market":"us","size":8923},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE6J3kCT32hZfxHnVt","market":"us","size":226192},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_002.jpg","type":"GRAPHIC","id":"NTFILE7wnPwnZCYPFzVGCm","market":"us","size":293530},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-1_003.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_003.jpg","type":"GRAPHIC","id":"NTFILE4nGGi33bTYVyEmtk","market":"us","size":238613},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-1_004.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_004.jpg","type":"GRAPHIC","id":"NTFILEErD6E6VmZUdrpjJy","market":"us","size":221426},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-1_005.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_005.jpg","type":"GRAPHIC","id":"NTFILE7q8Ck4reuJHvEvJ8","market":"us","size":231592},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-1_006.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_006.jpg","type":"GRAPHIC","id":"NTFILEByq7AuVNnR1PHx9C","market":"us","size":226509},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-1_007.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_007.jpg","type":"GRAPHIC","id":"NTFILEHYqqoJ3CduVfEMCp","market":"us","size":228694},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-1_008.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_008.jpg","type":"GRAPHIC","id":"NTFILE5Dik64zNXCCsVovG","market":"us","size":260613},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-1_009.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_009.jpg","type":"GRAPHIC","id":"NTFILE6u85xiuPWGLo9bW3","market":"us","size":332903},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-1_010.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_010.jpg","type":"GRAPHIC","id":"NTFILEJVTdTsCQgByiNoSg","market":"us","size":586566},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-1_011.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_011.jpg","type":"GRAPHIC","id":"NTFILE2yMirbhic8sppAXp","market":"us","size":554763},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-1_012.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_012.jpg","type":"GRAPHIC","id":"NTFILEDJ2DsAXwq5v6huSR","market":"us","size":337566},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-2_001.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_001.jpg","type":"GRAPHIC","id":"NTFILECpV1rZszDKrfL6YZ","market":"us","size":254134},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-2_002.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_002.jpg","type":"GRAPHIC","id":"NTFILEM239SsSu1Mi4Q1oW","market":"us","size":347467},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-2_003.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_003.jpg","type":"GRAPHIC","id":"NTFILEDu6oeiBAT8f5k9aK","market":"us","size":254269},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-2_004.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_004.jpg","type":"GRAPHIC","id":"NTFILE24s1aVx2p1YDZzXH","market":"us","size":222350},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-2_005.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_005.jpg","type":"GRAPHIC","id":"NTFILE9FCj8jQcByx3GC5H","market":"us","size":256507},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-2_006.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_006.jpg","type":"GRAPHIC","id":"NTFILE6MVaFJUFGGfLtPmZ","market":"us","size":226554},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-2_007.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_007.jpg","type":"GRAPHIC","id":"NTFILECTPFGHa1mkixy4Eu","market":"us","size":229340},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-2_008.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_008.jpg","type":"GRAPHIC","id":"NTFILE6pN78tp7pzaWWsiD","market":"us","size":296951},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-2_009.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_009.jpg","type":"GRAPHIC","id":"NTFILEGJMic3qLUvqQYqcs","market":"us","size":375596},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-2_010.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_010.jpg","type":"GRAPHIC","id":"NTFILE4gfFHy1SDu3YYwq7","market":"us","size":669531},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-2_011.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_011.jpg","type":"GRAPHIC","id":"NTFILECjwL2yN9E9UnEaSr","market":"us","size":645761},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022074705/ex99-2_012.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_012.jpg","type":"GRAPHIC","id":"NTFILEHqeEg5AjaeJxVxEw","market":"us","size":377822}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2022-11-23 00:00","pubTimestamp":1669132800,"title_zh":"8-K  - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01项：条例FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15616415","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390022067678-CRXT","pdf_url":"","pub_time":1667145600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"CRXT","title":"8-K  - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022067678/0001213900-22-067678-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.01: Completion of Acquisition or Disposition of Assets;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ASSET PURCHASE AGREEMENT, DATED AS OF OCTOBER 25, 2022, BY AND BETWEEN CLARUS TH","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022067678/ea167801ex2-1_clarusthera.htm","primary":true,"translateUrl":"","linkName":"ea167801ex2-1_clarusthera.htm","type":"EX-2.1","id":"NTFILEBvfLfSx6EN5TjJWV","market":"us","size":426816},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022067678/ea167801-8k_clarusthera.htm","primary":false,"translateUrl":"","linkName":"ea167801-8k_clarusthera.htm","type":"8-K","id":"NTFILE9gFLV6NviAu7eJHU","market":"us","size":39544}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2022-10-31 00:00","pubTimestamp":1667145600,"title_zh":"8-K  - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.01: Completion of Acquisition or Disposition of Assets;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订实质性最终协议；第2.01项：完成资产收购或处分；第5.02项：董事或某些高级职员离职；选举董事；某些官员的任命：某些官员的补偿安排；项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15589663","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390022065838-CRXT","pdf_url":"","pub_time":1666540800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"CRXT","title":"8-K  - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/0001213900-22-065838-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CLARUS THERAPEUTICS HOLDINGS, INC., MONTHLY OPERATING REPORT, DATED OCTOBER 21,","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ea167472ex99-1_clarusthera.htm","primary":true,"translateUrl":"","linkName":"ea167472ex99-1_clarusthera.htm","type":"EX-99.1","id":"NTFILE7VVh68YP9EbxmmrQ","market":"us","size":12722},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ea167472-8k_clarusthera.htm","primary":false,"translateUrl":"","linkName":"ea167472-8k_clarusthera.htm","type":"8-K","id":"NTFILE848XrYBAWV2PEmDB","market":"us","size":34406},{"description":"CLARUS THERAPEUTICS, INC., MONTHLY OPERATING REPORT, DATED OCTOBER 21, 2022","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ea167472ex99-2_clarusthera.htm","primary":false,"translateUrl":"","linkName":"ea167472ex99-2_clarusthera.htm","type":"EX-99.2","id":"NTFILE62LXwZiegBXy3UAx","market":"us","size":12679},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE74z4E9rZnR1FszhY","market":"us","size":154596},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_002.jpg","type":"GRAPHIC","id":"NTFILEEyBEtpCb6A5v2tHa","market":"us","size":194688},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-1_003.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_003.jpg","type":"GRAPHIC","id":"NTFILEH2xWnupfpTqT9cWR","market":"us","size":156758},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-1_004.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_004.jpg","type":"GRAPHIC","id":"NTFILE14WEU98jHTdjcRqs","market":"us","size":145982},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-1_005.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_005.jpg","type":"GRAPHIC","id":"NTFILEBzJpD8ycgskgGNQ5","market":"us","size":157224},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-1_006.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_006.jpg","type":"GRAPHIC","id":"NTFILE4gksc6B5xFrTqHxa","market":"us","size":146139},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-1_007.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_007.jpg","type":"GRAPHIC","id":"NTFILEdYd8Ly6aFxLhcZp1","market":"us","size":147027},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-1_008.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_008.jpg","type":"GRAPHIC","id":"NTFILE6rcVM6YKGymSiH95","market":"us","size":175743},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-1_009.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_009.jpg","type":"GRAPHIC","id":"NTFILEEEh825nC6ZM4qi7B","market":"us","size":229352},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-1_010.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_010.jpg","type":"GRAPHIC","id":"NTFILEGRQSfNNFkem8gyRu","market":"us","size":384643},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-1_011.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_011.jpg","type":"GRAPHIC","id":"NTFILE4mufKxKpzBR79NsV","market":"us","size":370133},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-1_012.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_012.jpg","type":"GRAPHIC","id":"NTFILE5aqiotExTSAhanzu","market":"us","size":224725},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-2_001.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_001.jpg","type":"GRAPHIC","id":"NTFILEAwk5eVUD4YeRsKTp","market":"us","size":154041},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-2_002.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_002.jpg","type":"GRAPHIC","id":"NTFILE8H8JYMf1rKoJLFqM","market":"us","size":206025},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-2_003.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_003.jpg","type":"GRAPHIC","id":"NTFILEEXDoc3iC5Eag8rfe","market":"us","size":156194},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-2_004.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_004.jpg","type":"GRAPHIC","id":"NTFILE2PE4q9bG5fp5Yn36","market":"us","size":148496},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-2_005.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_005.jpg","type":"GRAPHIC","id":"NTFILE7DEXj4FoU6EVERam","market":"us","size":159533},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-2_006.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_006.jpg","type":"GRAPHIC","id":"NTFILE2F1tdYrWbNP5d6N2","market":"us","size":149700},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-2_007.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_007.jpg","type":"GRAPHIC","id":"NTFILEbjY3qFUH5aFkortg","market":"us","size":150786},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-2_008.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_008.jpg","type":"GRAPHIC","id":"NTFILE6MHP1jZhwo66XhTT","market":"us","size":177744},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-2_009.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_009.jpg","type":"GRAPHIC","id":"NTFILEAjgfiyB4t4gzq5MC","market":"us","size":229284},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-2_010.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_010.jpg","type":"GRAPHIC","id":"NTFILEACuwBHgPiELp7pMa","market":"us","size":396245},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-2_011.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_011.jpg","type":"GRAPHIC","id":"NTFILEFzoh26NsfuMZ3fgW","market":"us","size":361189},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022065838/ex99-2_012.jpg","primary":false,"translateUrl":"","linkName":"ex99-2_012.jpg","type":"GRAPHIC","id":"NTFILE3szwCmrZ9EgRH68y","market":"us","size":222784}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2022-10-24 00:00","pubTimestamp":1666540800,"title_zh":"8-K  - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01项：条例FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15548698","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390022064699-CRXT","pdf_url":"","pub_time":1666022400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"CRXT","title":"8-K  - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022064699/0001213900-22-064699-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE OF CLARUS THERAPEUTICS HOLDINGS, INC., DATED OCTOBER 18, 2022.","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022064699/ea167269ex99-1_clarusthera.htm","primary":true,"translateUrl":"","linkName":"ea167269ex99-1_clarusthera.htm","type":"EX-99.1","id":"NTFILEGAEwVqVXAApZWt3E","market":"us","size":9104},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022064699/ea167269-8k_clarusthera.htm","primary":false,"translateUrl":"","linkName":"ea167269-8k_clarusthera.htm","type":"8-K","id":"NTFILE88P2r7KKa9p82oA5","market":"us","size":31283},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022064699/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEGQqKKZgHHDCGpca7","market":"us","size":3694}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2022-10-18 00:00","pubTimestamp":1666022400,"title_zh":"8-K  - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01：其他事件；项目9.01：财务报表和展品","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15447284","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390022056275-CRXT","pdf_url":"","pub_time":1663171200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"CRXT","title":"8-K  - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022056275/0001213900-22-056275-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 4.01: Changes in Registrant's Certifying Accountant;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"LETTER FROM RSM US LLP, DATED SEPTEMBER 15, 2022","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022056275/ea165839ex16-1_clarusthera.htm","primary":true,"translateUrl":"","linkName":"ea165839ex16-1_clarusthera.htm","type":"EX-16.1","id":"NTFILEfGPuFJQRBQaXj4ru","market":"us","size":2172},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022056275/ea165839-8k_clarusthera.htm","primary":false,"translateUrl":"","linkName":"ea165839-8k_clarusthera.htm","type":"8-K","id":"NTFILE5TVzSnfJnunAociz","market":"us","size":32847}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2022-09-15 00:00","pubTimestamp":1663171200,"title_zh":"8-K  - Current report","summary_en":"Item 4.01: Changes in Registrant's Certifying Accountant;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目4.01：注册人核证会计师的变更；项目9.01：财务报表和展品","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15447285","market":"us","labels":[],"media":"sec.gov","original_id":"AN135445722000518-CRXT","pdf_url":"","pub_time":1663084800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"25-NSE  - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities","symbol":"CRXT","title":"25-NSE  - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities","titleType":"交易所摘牌声明","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1817944/000135445722000518/0001354457-22-000518-index.htm","us_notice_code":"Form 25-NSE","us_title_en":"25-NSE  - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1354457/000135445722000518/xslF25X02/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"25-NSE","id":"NTFILECAgZ59ftLrE9DcVj","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Delisting","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"交易所摘牌声明","pubTime":"2022-09-14 00:00","pubTimestamp":1663084800,"title_zh":"25-NSE  - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15428143","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390022054293-CRXT","pdf_url":"","pub_time":1662393600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"CRXT","title":"8-K  - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022054293/0001213900-22-054293-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.03: Bankruptcy or Receivership;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE DATED SEPTEMBER 5, 2022.","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022054293/ea165390ex99-1_clarusthera.htm","primary":true,"translateUrl":"","linkName":"ea165390ex99-1_clarusthera.htm","type":"EX-99.1","id":"NTFILE27pNpkYdqF6b1QrS","market":"us","size":12024},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022054293/ea165390-8k_clarusthera.htm","primary":false,"translateUrl":"","linkName":"ea165390-8k_clarusthera.htm","type":"8-K","id":"NTFILE26NHWfxU31qYA9Nj","market":"us","size":35819},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000121390022054293/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILE3ZTprQf41L5o5MSK","market":"us","size":3694}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2022-09-06 00:00","pubTimestamp":1662393600,"title_zh":"8-K  - Current report","summary_en":"Item 1.03: Bankruptcy or Receivership;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目1.03：破产或破产管理；项目5.02：董事或某些高级人员离职；选举董事；某些人员的任命：某些人员的补偿安排；项目8.01：其他事件；项目9.01：财务报表和展品","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15365569","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312522231320-CRXT","pdf_url":"","pub_time":1661443200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"CRXT","title":"8-K  - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1817944/000119312522231320/0001193125-22-231320-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000119312522231320/d400117d8k.htm","primary":true,"translateUrl":"","linkName":"d400117d8k.htm","type":"8-K","id":"NTFILE67deiGse4aBiMsq4","market":"us","size":26276}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2022-08-26 00:00","pubTimestamp":1661443200,"title_zh":"8-K  - Current report","summary_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing","summary_zh":"项目3.01：退市或不符合继续上市规则或标准的通知；上市转让","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15322067","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312522224410-CRXT","pdf_url":"","pub_time":1660838400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-Q  - Quarterly report [Sections 13 or 15(d)]","symbol":"CRXT","title":"10-Q  - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1817944/000119312522224410/0001193125-22-224410-index.htm","us_notice_code":"Form 10-Q","us_title_en":"10-Q  - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000119312522224410/d373515d10q.htm","primary":true,"translateUrl":"","linkName":"d373515d10q.htm","type":"10-Q","id":"NTFILE9AzTYKQYGSHZt3Nr","market":"us","size":1172410},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000119312522224410/d373515dex311.htm","primary":false,"translateUrl":"","linkName":"d373515dex311.htm","type":"EX-31.1","id":"NTFILE4WBZug8UsW8xQZmd","market":"us","size":11659},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000119312522224410/d373515dex312.htm","primary":false,"translateUrl":"","linkName":"d373515dex312.htm","type":"EX-31.2","id":"NTFILEwXX9xFRmWoAP4NVo","market":"us","size":11674},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000119312522224410/d373515dex321.htm","primary":false,"translateUrl":"","linkName":"d373515dex321.htm","type":"EX-32.1","id":"NTFILE2r2T79PxgBm4Fnth","market":"us","size":3806},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1817944/000119312522224410/d373515dex322.htm","primary":false,"translateUrl":"","linkName":"d373515dex322.htm","type":"EX-32.2","id":"NTFILEEbkbzMW3ByVjkT6c","market":"us","size":3821}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2022-08-19 00:00","pubTimestamp":1660838400,"title_zh":"10-Q  - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.clarustherapeutics.com;www.jatenzo.com","description":"Clarus Therapeutics Holdings, Inc.是一家于2020年5月22日在特拉华州注册成立的公司。该公司是一家制药公司，在开发男性和女性雄激素和代谢疗法方面具有专业知识，包括针对孤儿适应症的潜在疗法。公司的第一个商业产品是JATENZO。","exchange":"PINK","name":"Clarus Therapeutics Holdings, Inc.","nameEN":"Clarus Therapeutics Holdings, Inc."},"aProfile":null}}}

Clarus Therapeutics Holdings, Inc.

公司概况

热议股票